Editorial: Combination Strategies in the Treatment of Melanoma

Por Ascierto, Paolo Antonio
Publicado no Front Oncol (2016)

Melanoma: the role of surgery in the era of new therapies

Por Mozzillo, Nicola, Ascierto, Paolo A
Publicado em 2014

Adjuvant therapy of melanoma with interferon: lessons of the past decade

Por Ascierto, Paolo A, Kirkwood, John M
Publicado em 2008

Combination therapy: the next opportunity and challenge of medicine

Por Ascierto, Paolo A, Marincola, Francesco M
Publicado em 2011

What have we learned from cancer immunotherapy in the last 3 years?

Por Ascierto, Paolo A, Marincola, Francesco M
Publicado em 2014

2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond

Por Ascierto, Paolo A., Marincola, Francesco M.
Publicado no EBioMedicine (2015)

Melanoma: A model for testing new agents in combination therapies

Por Ascierto, Paolo A, Streicher, Howard Z, Sznol, Mario
Publicado em 2010

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application

Por Ascierto, Paolo A, Marincola, Francesco M, Ribas, Antoni
Publicado em 2011

Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy

Por Ascierto, Maria Libera, Melero, Ignacio, Ascierto, Paolo Antonio
Publicado no Front Oncol (2015)

What’s new in melanoma? Combination!

Por Ascierto, Paolo A, Marincola, Francesco M, Atkins, Michael B
Publicado no J Transl Med (2015)

NF-κB as potential target in the treatment of melanoma

Por Madonna Gabriele, Ullman Claudio, Gentilcore Giusy, Palmieri Giuseppe, Ascierto Paolo
Publicado em 2012-03-01

Melanoma: From Research to Treatment

Por Ascierto, Paolo A., Kirkwood, John M., Marincola, Francesco M., Palmieri, Giuseppe
Publicado em 2011

Tumor biobanks in translational medicine

Por Botti, Gerardo, Franco, Renato, Cantile, Monica, Ciliberto, Gennaro, Ascierto, Paolo Antonio
Publicado em 2012

NF-κB as potential target in the treatment of melanoma

Por Madonna, Gabriele, Ullman, Claudio Dansky, Gentilcore, Giusy, Palmieri, Giuseppe, Ascierto, Paolo Antonio
Publicado em 2012

The Role of Optical Radiations in Skin Cancer

Por Ayala, Fabrizio, Palla, Marco, Di Trolio, Rossella, Mozzillo, Nicola, Ascierto, Paolo A.
Publicado em 2013

Report from the second MIB (Melanoma Independent Board) Conference, 27–28 October 2014

Por Testori, Alessandro, Rossi, Carlo Riccardo, Ascierto, Paolo, de Lorenzo, Francesco, Mozzillo, Nicola
Publicado no Ecancermedicalscience (2015)

Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma

Por Hoeller, Christoph, Michielin, Olivier, Ascierto, Paolo A., Szabo, Zsolt, Blank, Christian U.
Publicado no Cancer Immunol Immunother (2016)

Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials

Por Dummer, Reinhard, Schadendorf, Dirk, Ascierto, Paolo A, Larkin, James, Lebbé, Celeste, Hauschild, Axel
Publicado em 2014

Genetic instability and increased mutational load: which diagnostic tool best direct patients with cancer to immunotherapy?

Por Palmieri, Giuseppe, Colombino, Maria, Cossu, Antonio, Marchetti, Antonio, Botti, Gerardo, Ascierto, Paolo A.
Publicado no J Transl Med (2017)

Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use

Por Ascierto, Paolo A, Simeone, Ester, Giannarelli, Diana, Grimaldi, Antonio M, Romano, Anna, Mozzillo, Nicola
Publicado em 2012